Stockreport

Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA [Yahoo! Finance]

Simulations Plus, Inc.  (SLP) 
Last simulations plus, inc. earnings: 4/9 04:35 pm Check Earnings Report
US:NASDAQ Investor Relations: simulations-plus.com/software/overview
PDF DILIsym is a modernized Quantitative Systems Toxicology software for forecasting and analyzing drug-induced liver injury (DILI). The software is specifically engineered [Read more]